Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism

Direct oral anticoagulants (DOACs) have become the standard of care for acute and long-term therapy for venous thromboembolism (VTE) due to their efficacy and safety profiles. The 2021 International Society on Thrombosis and Haemostasis guidelines recommend using standard DOAC dosages in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dah, Kingsley, Porres-Aguilar, Mateo, la Rosa, Alan De, Prakash, Swathi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2023
Materias:
Therapeutic Challenge
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421569/
https://www.ncbi.nlm.nih.gov/pubmed/37576730
http://dx.doi.org/10.1590/1677-5449.202300562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421569/
https://www.ncbi.nlm.nih.gov/pubmed/37576730
http://dx.doi.org/10.1590/1677-5449.202300562

Ejemplares similares